Inventor · disambiguated record
John Öhd
Also filed as: OHD JOHN · ÖHD JOHN
3 granted patents·1 pending application·3 citations·filing 2017–2024
57Inventor score
Files withMEDIVIR AB4
Top patents by PatentIndex Score
4 records- 0183US10456413B2Combination therapy with sorafenib or regorafenib and a phosphoramidate prodrug of troxacitabineMEDIVIR AB·Filed 2017·Granted Oct 29, 2019·2 cites·20 claims
- 0273US12479870B2Base-modified cytidine nucleotides for leukemia therapyMEDIVIR AB·Filed 2024·Granted Nov 25, 2025·0 cites·17 claims
- 0372US10960017B2Sorafenib or regorafenib troxacitabine phosphoramidate prodrug combination therapy for liver cancerMEDIVIR AB·Filed 2019·Granted Mar 30, 2021·1 cites·15 claims
- 0446US2021261584A1Base-Modified Cytidine Nucleotides for Leukemia TherapyMEDIVIR AB·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Öhd files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →